NYSE · NHIReal EstateREITs

National Health Investors news

$66.66−0.27%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days1English, de-duplicated
Positive00% of coverage
Neutral00%
Negative1100% of coverage

About National Health Investors

CUZ vs. NHI: Which Stock Should Value Investors Buy Now?
Zacks Investment ResearchAug 31, 11:40 AM ET▼ Negative

NHI shows weaker metrics with a Zacks Rank #4 (Sell), higher forward P/E ratio of 15.07, higher PEG ratio of 3.83, higher P/B ratio of 2.21, and a lower Value grade of C, indicating it is less attractive for value investors.

NHI Announces the Second Quarter 2026 Dividend
BenzingaMay 4, 4:20 PM ET▲ Positive

The company is maintaining its dividend payments at $0.92 per share, demonstrating financial stability and commitment to shareholders. Regular dividend announcements are typically viewed positively as they indicate consistent cash flow generation and management confidence in the business outlook.

Also mentions NHI

Articles that tag NHI but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology